Today's trade idea revolves around a biopharma concern that is awaiting a critical FDA decisionA negative opinion could well cut the shares in halfHowever, with this option strategy, one can mitigate approximately two-thirds of those potential lossesFDA approval might mean leaving some money on the table as well, but still booking 50% gainsA posit...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.